18/03/2026 07:30
SENSORION : Inside Information / News release on accounts, results
Press Release Sensorion Reports FullYear 2025 Results, Provides Corporate Update and Announces Release of Annual Report • GJB2GT SENS601 CTA/INDenabling studies progress, supported by regulatory interactions with FDA and EMA since Q3 2025, and on... Lire...
18/03/2026 07:02
EQS-News: FY 2025: HelloFresh SE continues to show strong AEBITDA performance while efficiency program progresses meaningfully
html xmlns=http://www.w3.org/1999/xhtmlbody table border=trtd p EQSNews: HelloFresh SE / Key words: Annual Results br/ FY 2025: HelloFresh SE continues to show strong AEBITDA performance while efficiency program progresses meaningfully... Lire...
18/03/2026 07:00
INVESTIS Holding SA : Investis delivers strong performance – Higher dividend of CHF 3.00 proposed
html xmlns=http://www.w3.org/1999/xhtmlbody table border= cellpadding= cellspacing=trtd pINVESTIS Holding SA / Key words: Annual Resultsbr/ Investis delivers strong performance – Higher dividend of CHF 3.00 proposed br/br/span18March2026 / 07:00... Lire...
18/03/2026 07:00
BioVersys AG : BioVersys Reports Corporate Highlights and Financial Results for the Full Year 2025
html xmlns=http://www.w3.org/1999/xhtmlbody table border= cellpadding= cellspacing=trtd pBioVersys AG / Key words: Annual Resultsbr/ BioVersys Reports Corporate Highlights and Financial Results for the Full Year 2025 br/br/span18March2026 / 07:00... Lire...
18/03/2026 07:00
EQS-News: Newron announces nominations to its Board of Directors at upcoming Annual General Meeting
html xmlns=http://www.w3.org/1999/xhtmlbody table border=trtd p EQSNews: Newron Pharmaceuticals S.p.A. / Key words: Personnel br/ Newron announces nominations to its Board of Directors at upcoming Annual General Meeting br/br/ 18.03.2026 /... Lire...
18/03/2026 07:00
EQS-News: Blue Cap AG publishes preliminary financial figures for 2025: successful financial year 2025
html xmlns=http://www.w3.org/1999/xhtmlbody table border=trtd p EQSNews: Blue Cap AG / Key words: Preliminary Results br/ Blue Cap AG publishes preliminary financial figures for 2025: successful financial year 2025 br/br/ 18.03.2026 / 07:00... Lire...
18/03/2026 07:00
Press Release: Sanofi’s venglustat earns Breakthrough Therapy designation in the US for type 3 Gaucher disease
Press Release Sanofi’s venglustat earns Breakthrough Therapy designation in the US for type 3 Gaucher disease Paris, March 18, 2026. The US Food and Drug Administration FDA has granted Breakthrough Therapy designation to venglustat, a novel, investigational... Lire...
18/03/2026 07:00
2025 annual results: strong improvement in financial earnings and cash-flows
p align=right style=marginleft:40px;strong  Press release/strong/p p align=rightParis, March 18, 2026 at 7 a.m./p p /p pstrongKey figures for the 2025 financial year/strong/p ul liRecord strongorder intake/strong of €844 million, up 87%./li listrongRevenue growth /strongof... Lire...